Today's Top Health News Story

Government costs could rise $2.3 billion without Obamacare payments: study

WASHINGTON (Reuters) - The U.S. government's costs could increase by $2.3 billion in 2018 if Congress and President Donald Trump decide not to fund Obamacare-related payments to health insurers, according to a study released Tuesday by the Kaiser Family Foundation. Learn More

 

More Top Health Stories

Ok to wait for colonoscopy after positive fecal test results

(Reuters Health) - People who wait up to nine months to get a colonoscopy after fecal tests show potential tumors are no more likely to be diagnosed with cancer or advanced malignancies than those who get follow-up colonoscopies sooner, a U.S. study suggests. More »

 

Swedish authorities says bird flu found at hen farm

STOCKHOLM (Reuters) - An outbreak of H5N8 bird flu has been detected at a hen farm near the town of Nykoping in eastern Sweden, the country's board of agriculture said on Tuesday. More »

 

Novartis to speed up bid for MS drug approval, changes target

ZURICH (Reuters) - Novartis said on Tuesday it would accelerate its bid to win approval for its experimental multiple sclerosis (MS) drug BAF312 and said it was now targeting patients at an earlier stage of the neurological disease. More »

 

White House says vote on healthcare plan may not come for weeks

WASHINGTON (Reuters) - A congressional vote on a Republican healthcare plan may not come for weeks as leaders in the House of Representatives and the Senate continue negotiations over possible proposals, the White House said on Monday. More »

 

Taiwan eyes U.N. health meet, risks setback in China ties

TAIPEI (Reuters) - Taiwan faces a more complicated task this year in seeking to attend a U.N. health agency meeting than it has in the past, a senior official said on Tuesday, as the self-ruled island braces for another setback in ties with rival China. More »

 

Novartis sets sights on return to growth in 2018

ZURICH (Reuters) - Novartis reported better-than-expected first-quarter profits on Tuesday with Chief Executive Joe Jimenez saying he remained confident the Swiss drugmaker would return to growth in 2018 as spending to promote new drugs pays off. More »

 

AstraZeneca moving costs rise as new HQ nears completion

LONDON (Reuters) - AstraZeneca's move to the English university city of Cambridge will cost more and take longer than initially expected, following increased expenditure on new technology and equipment. More »

 

Health insurer Centene's quarterly profit, revenue beat Street

(Reuters) - Health insurer Centene Corp reported better-than-expected quarterly revenue and profit, helped by its Health Net acquisition and growth in its Obamacare individual business. More »

 

Biogen profit beats on surprisingly strong Spinraza sales

(Reuters) - Biogen Inc's quarterly profit blew past analysts' estimates, helped by higher-than-expected sales of its recently launched spinal muscular atrophy drug, Spinraza. More »

 

News, Photo and Web Search